By carefully choosing the most suitable probe for your assay, you can enhance data accuracy, improve reproducibility, and streamline logistics and troubleshooting options.
Unlocking optimal results in your assay requires some experimentation with multiple probe types at assay development stage.
To help you in this process, LGC Biosearch Technologies has developed an tool that will recommend probe types based on your experimental conditions. This online probe selection tool provides general guidance on assay suitability and performance, introducing you to various probe technologies.
Available probes include:
- BHQTM Probes
- BHQplusTM Probes
- MGB Probes
- Locked Nucleic acid (LNA) Probes
- Molecular Beacon Probes
- ScorpionsTM Primers
- Other probes: FRET probes, FPG/RPA probes, HyBeacon probes, Amplifluor oligos and others. Please contact Biosearch Technologies to learn more.
If you have further questions regarding your assay or require additional technical support for assay design and development, contact the Biosearch Technologies assay design and development team who will assist you.
About LGC Biosearch Technologies
Together, we help you advance.
Whether you’re using marker-assisted selection to develop more nutritious and sustainable crops or developing the next generation of molecular diagnostic tests, clinical genomics assays, or novel oligo therapeutics, accurate and high-quality data is everything. And so is speed.
To help keep your mission-critical projects on target and moving quickly, LGC provides a large integrated portfolio of products and services to support your entire genomics workflow and help at every stage of your product development pipeline. From R&D through to large-scale commercialization, our products and services scale up when you do.
Watch the video to see how our unified genomics portfolio helps you discover more, speeding up your work to improve the human condition.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.